Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | CNR1 | P21554 | 3/20 | 0.39 |
| ▸ | CNR2 | P34972 | 3/20 | 0.39 |
| ▸ | ACLY | P53396 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HTR1D | P28221 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TYR | P14679 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10183607 | 0.94 | GABRA1 (0.52) | TSHRGABRA1GABRB2POLBGAA | |
| SCHEMBL25289427 | 0.84 | GABRA1 (0.44) | TSHRGABRA1GABRB2POLBGAA | |
| SCHEMBL8826911 | 0.84 | POLB (0.41) | TSHRGABRA1GABRB2POLBGAA | |
| SCHEMBL13249067 | 0.82 | RAPGEF4 (0.44) | TSHRGABRA1GABRB2POLBACLY | |
| SCHEMBL9967852 | 0.82 | GABRA1 (0.37) | TSHRGABRA1GABRB2POLBGAA | |
| SCHEMBL31465128 | 0.82 | GABRA1 (0.37) | TSHRGABRA1GABRB2POLBGAA | |
| SCHEMBL16953294 | 0.82 | GABRA1 (0.37) | TSHRGABRA1GABRB2POLBGAA | |
| SCHEMBL24019453 | 0.82 | GABRA1 (0.37) | TSHRGABRA1GABRB2POLBGAA | |
| SCHEMBL20933032 | 0.82 | GABRA1 (0.48) | TSHRGABRA1GABRB2POLBGAA | |
| SCHEMBL13208190 | 0.82 | GABRA1 (0.37) | TSHRGABRA1GABRB2POLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 330 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260007074-A1 | LIGHT-EMITTING ELEMENT, POLYCYCLIC COMPOUND FOR THE SAME, AND DISPLAY DEVICE INCLUDING THE LIGHT-EMITTING ELEMENT | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-01-01 | — | — | US | disclosed |
| US-20260007073-A1 | LIGHT-EMITTING ELEMENT, FUSED POLYCYCLIC COMPOUND FOR THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2026-01-01 | — | — | US | disclosed |
| US-20250338772-A1 | LIGHT EMITTING ELEMENT, FUSED POLYCYCLIC COMPOUND FOR THE LIGHT EMITTING ELEMENT, AND DISPLAY DEVICE INCLUDING THE LIGHT EMITTING ELEMENT | SAMSUNG DISPLAY CO LTD (KR) | 2025-10-30 | — | — | US | disclosed |
| US-20250287842-A1 | LIGHT EMITTING ELEMENT, POLYCYCLIC COMPOUND FOR THE SAME, AND ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-09-11 | — | — | US | disclosed |
| US-20250098539-A1 | LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS AND ELECTRONIC DEVICE EACH INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-03-20 | — | — | US | disclosed |
| US-20240315135-A1 | LIGHT EMITTING ELEMENT AND FUSED POLYCYCLIC COMPOUND FOR LIGHT EMITTING ELEMENT | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-09-19 | — | — | US | disclosed |
| CN-118530270-A | Light-emitting element and condensed polycyclic compound for light-emitting element | 三星显示有限公司 | 2024-08-23 | — | — | CN | disclosed |
| US-20240260291-A1 | LIGHT EMITTING DEVICE AND FUSED POLYCYCLIC COMPOUND FOR THE LIGHT EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-08-01 | — | — | US | disclosed |
| US-20240239821-A1 | N-ACYL FOSMIDOMYCIN PRODRUG ANALOGS AS NOVEL ANTIINFECTIVE AGENTS | THE GEORGE WASHINGTON UNIVERSITY | 2024-07-18 | — | — | US | disclosed |
| US-20240239821-A1 | N-ACYL FOSMIDOMYCIN PRODRUG ANALOGS AS NOVEL ANTIINFECTIVE AGENTS | THE GEORGE WASHINGTON UNIVERSITY | 2024-07-18 | — | — | US | disclosed |
| US-20070066598-A1 | Compounds | BIOVITRUM AB, A SWEDEN CORPORATION | 2007-03-22 | — | — | US | disclosed |
| US-20070037855-A1 | Compounds for inhibiting beta-amyloid production and methods of identifying the compounds | ALZHEIMER'S INSTITUTE OF AMERICA, INC. | 2007-02-15 | — | — | US | disclosed |
| US-7176231-B2 | Aryl-containing 5-acylindolinones, the preparation thereof and their use as medicaments | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-02-13 | — | — | US | disclosed |
| US-20070027321-A1 | Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 | MERCK SHARP & DOHME CORP. | 2007-02-01 | — | — | US | disclosed |
| US-7166603-B2 | Dihydropyrimidone inhibitors of calcium channel function | BRISTOL-MYERS SQUIBB CO. (US) | 2007-01-23 | — | — | US | disclosed |
| US-20070015758-A1 | Novel benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors | DR. REDDY'S LABORATORIES LTD. (IN) | 2007-01-18 | — | — | US | disclosed |
| US-20070015758-A1 | Novel benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors | DR. REDDY'S LABORATORIES LTD. (IN) | 2007-01-18 | — | — | US | disclosed |
| US-20040082496-A1 | ACE-2 modulating compounds and methods of use thereof | MILLENNIUM PHARMACEUTICALS, INC. | 2004-04-29 | — | — | US | disclosed |
| US-20040082578-A1 | Arylindenopyridines and related therapeutic and prophylactic methods | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2004-04-29 | — | — | US | disclosed |
| US-6512006-B1 | Novel 3-position Nitrogen substituted 6,6- disubstituted-5, 6-dihydropyrones and related compounds possess antiviral properties | WARNER-LAMBERT COMPANY | 2003-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040082496-A1 | ACE-2 modulating compounds and methods of use thereof | ACE, ACE2, AGTR2 | TSHR 2420/4885GABRA1 1098/4885GABRB2 454/4885 |
| US-20040082578-A1 | Arylindenopyridines and related therapeutic and prophylactic methods | ADORA2A, ADORA1, PDE2A | TSHR 818/4885GABRA1 500/4885GABRB2 386/4885 |
| US-20070066598-A1 | Compounds | SULT2A1, STS, SLC5A2 | TSHR 1299/4885GABRA1 912/4885GABRB2 421/4885 |
| US-20260007074-A1 | LIGHT-EMITTING ELEMENT, POLYCYCLIC COMPOUND FOR THE SAME, AND DISPLAY DEVICE INCLUDING THE LIGHT-EMITTING ELEMENT | CCNL2, CRY1, CCNA1 | TSHR 1977/4885GABRA1 3013/4885GABRB2 3212/4885 |
| US-20240315135-A1 | LIGHT EMITTING ELEMENT AND FUSED POLYCYCLIC COMPOUND FOR LIGHT EMITTING ELEMENT | NR2E3, LEF1, NFE2L2 | TSHR 4114/4885GABRA1 1407/4885GABRB2 1515/4885 |
| US-20260007073-A1 | LIGHT-EMITTING ELEMENT, FUSED POLYCYCLIC COMPOUND FOR THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE SAME | NFE2L2, CCNL2, INF2 | TSHR 3235/4885GABRA1 3681/4885GABRB2 3267/4885 |
| US-20070037855-A1 | Compounds for inhibiting beta-amyloid production and methods of identifying the compounds | APP, PSEN1, PSEN2 | TSHR 4253/4885GABRA1 1294/4885GABRB2 435/4885 |
| US-20250287842-A1 | LIGHT EMITTING ELEMENT, POLYCYCLIC COMPOUND FOR THE SAME, AND ELECTRONIC DEVICE INCLUDING THE SAME | NFE2L2, ELP1, LAGE3 | TSHR 4355/4885GABRA1 2592/4885GABRB2 3076/4885 |
| US-20070027321-A1 | Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 | GRM5, GRIK5, GRM1 | TSHR 692/4885GABRA1 51/4885GABRB2 74/4885 |
| US-20250338772-A1 | LIGHT EMITTING ELEMENT, FUSED POLYCYCLIC COMPOUND FOR THE LIGHT EMITTING ELEMENT, AND DISPLAY DEVICE INCLUDING THE LIGHT EMITTING ELEMENT | NR2E3, CRY1, LAGE3 | TSHR 3181/4885GABRA1 753/4885GABRB2 1120/4885 |
| US-20070015758-A1 | Novel benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors | CETP, NPC1, DBI | TSHR 3907/4885GABRA1 3300/4885GABRB2 2842/4885 |
| US-20240239821-A1 | N-ACYL FOSMIDOMYCIN PRODRUG ANALOGS AS NOVEL ANTIINFECTIVE AGENTS | PSPH, PGLS, DNPEP | TSHR 3740/4885GABRA1 3724/4885GABRB2 3759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.